Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXTEND: Exercise with Enzalutamide in Prostate Cancer
NCT02256111Phase 2Completed
- Sponsor
- Duke University
- Start
- May 2015
- Primary completion
- Feb 2018
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Duke University. Primary endpoint: Change in Peak Oxygen Uptake at 17 weeks. Started May 2015; status: completed.
Beyond the preview
Go deeper on NCT02256111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02256111.